Roche CDR (CAD Hedged) (ROG:TSX) closed at $31.71 on November 12, 2026, down 1.12% on the day. The stock trades 1.6% below its 52-week high of $32.23 and 40.6% above its 52-week low of $22.55. Over the past year, it gained 40.6%. Roche CDR (CAD Hedged) is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, ROG closed higher on 117 days (46%). Its best day was November 18, 2025 (+7.32%) and its worst was June 2, 2026 (-5.49%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 3 times.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Find more stocks like ROG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.